Subscribe for the newsletter
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Kidney Disease
Sort By
Newest First
Sign in
1 / 1
1 / 1
Kidney Disease
Ascelia Pharma Meets Major Milestone with Patient Enrollment Completion of Phase 3 Study for Orviglance, Novel MRI Contrast Agent for Patients with Kidney Impairment
Ascelia Pharma
PR-M02-23-04
Feb 27, 2023
Collaboration
Baxter and the International Society of Nephrology Announce a Collaboration to Address Growing Prevalence of Kidney Disease
Baxter
PR-M05-18-NI-025
May 07, 2018
